• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form RW filed by Ridgetech Inc.

    10/22/25 4:15:17 PM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $RDGT alert in real time by email
    RW 1 ea0262109-rw_ridgetech.htm WITHDRAWAL REQUEST

    Ridgetech, Inc.

    5th Floor, Building 6, No. 100, 18th Street, Baiyang Sub-district

    Qiantang District, Hangzhou City, Zhejiang Province

    People’s Republic of China, 310008

     

    October 22, 2025

     

    VIA EDGAR

     

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    Office of Trade & Services

    100 F Street, N.E.

    Washington, D.C. 20549

     

    RE: Ridgetech, Inc.

    Withdrawal of Registration Statement on Form F-1

    File No. 333-290522

     

    Ladies and Gentlemen:

     

    Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Ridgetech, Inc. (the “Registrant”) hereby respectfully requests that the U.S. Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Registrant’s Registration Statement on Form F-1 (File No. 333-290522) together with all exhibits and amendments thereto (collectively, the “Registration Statement”) initially filed with the Commission on September 25, 2025.

     

    The Registrant has determined not to pursue the public offering to which the Registration Statement relates at this time. The Registration Statement has not been declared effective by the Commission and the Registrant confirms that no securities have been sold pursuant to the Registration Statement. Accordingly, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477. Pursuant to paragraph (c) of Rule 477, the Registrant advises the Commission that it may, upon consideration of its financing and strategic options, undertake a subsequent private offering in reliance on Rule 152 promulgated under the Securities Act.

     

    The Company acknowledges that no refund will be made for fees paid to the Commission in connection with the filing of the Registration Statement. However, the Company requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use should the Company proceed with the filing of a subsequent registration statement meeting the requirements of Rule 457(p) promulgated under the Securities Act.

     

    Should you have any questions regarding this request, please do not hesitate to contact counsel to the Registrant, Yan Zhang of Norton Rose Fulbright US LLP at (628) 231-6821, or in his absence, Siyuan An at (213) 892-9354. 

     

    Sincerely,  
       
    Ridgetech, Inc.  
         
    By:

    /s/ Ming Zhao

     
    Name:  Ming Zhao  
    Title: Interim Chief Executive Officer and Chief Financial Officer  

     

    cc:Yan Zhang, Norton Rose Fulbright US LLP

    Siyuan An, Norton Rose Fulbright US LLP

     

    Get the next $RDGT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDGT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RDGT
    SEC Filings

    View All

    SEC Form 6-K filed by Ridgetech Inc.

    6-K - Ridgetech Inc. (0001856084) (Filer)

    4/10/26 5:00:31 PM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by Ridgetech Inc.

    6-K - Ridgetech Inc. (0001856084) (Filer)

    4/3/26 12:00:02 PM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by Ridgetech Inc.

    6-K - Ridgetech Inc. (0001856084) (Filer)

    3/5/26 4:30:37 PM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $RDGT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ridgetech, Inc. Announces 1-for-150 Reverse Share Split

    HANGZHOU, China, April 3, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (NASDAQ:RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-150 reverse share split on its ordinary shares ("Ordinary Shares") effective Tuesday, April 7, 2026 at 5:00 p.m. Eastern Time, with trading to begin on a split‑adjusted basis at the market open on the next trading day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "RDGT." The new CUSIP number for the Ordinary Shares following the reverse share split is G2124G 203. As of April 2, 2026, the

    4/3/26 12:00:00 PM ET
    $CJJD
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value Creation

    HANGZHOU, China, March 4, 2026 /PRNewswire/ -- Ridgetech, Inc. (NASDAQ:RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its dual-engine growth strategy for 2026. The strategy centers on supply chain integration by leveraging its wholesale distribution network, B2B platform, and franchise system. Building on its integrated pharmaceutical and healthcare service platforms, Ridgetech aims to achieve parallel breakthroughs in both business model innovation and value creation, thereby strengthening its long-term growth foundation across China's pharmaceutical and healthcare supply chain. Further Strengthening Co

    3/4/26 8:30:00 AM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results

    HANGZHOU, China, July 28, 2025 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2025. Mr. Frank Zhao, Interim Chief Executive Officer and Chief Financial Officer of Ridgetech, commented, "We are pleased to present a relatively stable revenue outcome for fiscal year 2025, a year marked by significant transformation for the Company. During this period, we divested our retail pharmacy business and acquired Ridgeline and its subsidiary, Allright (Hangzhou) Internet Technology Co. Ltd ("Allright"), marking our st

    7/28/25 9:00:00 AM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $RDGT
    Financials

    Live finance-specific insights

    View All

    Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results

    HANGZHOU, China, July 28, 2025 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2025. Mr. Frank Zhao, Interim Chief Executive Officer and Chief Financial Officer of Ridgetech, commented, "We are pleased to present a relatively stable revenue outcome for fiscal year 2025, a year marked by significant transformation for the Company. During this period, we divested our retail pharmacy business and acquired Ridgeline and its subsidiary, Allright (Hangzhou) Internet Technology Co. Ltd ("Allright"), marking our st

    7/28/25 9:00:00 AM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples